'Classical' and 'new' diabetogens--comparison of their effects on isolated rat pancreatic islets in vitro.
This study compares functional and morphological alterations caused by application of alloxan, streptozotocin, xanthine oxidase/hypoxanthine (generation of reactive oxygen species), or S-nitroso-N-acetyl-D,L-penicillamine (SNAP, liberation of nitric oxide) to isolated rat pancreatic islets in vitro. In perifusion experiments, membrane leakage--detected by non-stimulated insulin release--was found after application of all drugs, but showed a substance-specific time pattern. Twenty-four hours after application of the classical diabetogens (alloxan or streptozotocin), potassium chloride- and glucose-stimulated insulin secretion were markedly reduced, while a persistent reduction was observed neither after exposure to xanthine oxidase/hypoxanthine, nor to SNAP. Morphological analysis of the islets revealed that nearly all beta-cells were destroyed following alloxan or streptozotocin treatment, while the majority of beta-cells were configured regularly after application of xanthine oxidase/hypoxanthine or SNAP. Necrotic cells found after xanthine oxidase/hypoxanthine usually differed in morphology from those observed after application of the classical diabetogens. While the former cells were characterised by swollen nuclei, the latter had shrunken nuclei with irregular condensed chromatin. Apoptosis was found only following nitric oxide exposure. Due to these differences, it seems unlikely that alloxan, streptozotocin, xanthine oxidase/hypoxanthine, and nitrix oxide have a common major feature in their toxic action.
Peschke
E
E
Institute of Anatomy and Cell Biology, Martin Luther University, Halle-Wittenberg, Saale, Germany.
Ebelt
H
H
Brömme
H J
HJ
Peschke
D
D
D000496:Alloxan / Q000633:toxicity; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002467:Cell Nucleus / Q000187:drug effects / Q000473:pathology; D048429:Cell Size / Q000187:drug effects; D002478:Cells, Cultured; D003921:Diabetes Mellitus, Experimental / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology*; D005260:Female; D005947:Glucose / Q000494:pharmacology; D019271:Hypoxanthine / Q000378:metabolism / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure; D008297:Male; D008854:Microscopy, Electron; D009569:Nitric Oxide / Q000378:metabolism / Q000633:toxicity; D020030:Nitric Oxide Donors / Q000378:metabolism / Q000633:toxicity; D010396:Penicillamine / Q000031:analogs & derivatives / Q000378:metabolism / Q000633:toxicity; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species / Q000378:metabolism; D013311:Streptozocin / Q000633:toxicity; D014969:Xanthine Oxidase / Q000378:metabolism / Q000494:pharmacology
D007328:Insulin; D020030:Nitric Oxide Donors; D017382:Reactive Oxygen Species; C110881:S-nitro-N-acetylpenicillamine; D019271:Hypoxanthine; D009569:Nitric Oxide; D013311:Streptozocin; D011189:Potassium Chloride; D000496:Alloxan; D014969:Xanthine Oxidase; D010396:Penicillamine; D005947:Glucose